Report ID: 10079041 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Interventional Oncology Industry was valued at USD 2 Billion in the year 2019. Global Interventional Oncology Industry is further estimated to grow at a CAGR of 7.5% from 2019 to reach USD 3.28 Billion by the year 2025.
The development of this market is principally determined by the rising inclination for negligibly intrusive techniques, extension of the objective patient populace, expanding open private subsidizing and government support for disease inquire about, mechanical progressions in the field of interventional oncology, and expanding government ventures and funding for interventional oncology and related cancer research.
The increasing demand for minimally invasive MI procedures is driving the growth of the global interventional oncology industry. The increasing awareness about the benefits of MI surgeries, such as reduced risk of shorter hospital stay, infection, minimal complications, lesser pain, and a faster recovery time when compared to the conventional open surgeries, are encouraging patients and surgeons to opt for MI surgeries, resulting in the high growth of this industry. The global interventional oncology industry will continue to be driven by these factors over the coming years.
The increasing demand of image-guided solutions in interventional oncology industry procedures, thanks to the improvement of these solutions provide in the treatment and diagnosis of cancer-related issues, is also expected to supplement the growth prospects of this industry in the near future.
In the presence of a number of local and international vendors characterizes the business landscape of the global industry for interventional oncology, which is highly competitive and diversified. Technological advancements and constant introduction of new products are likely to intensify the competitive environment in the industry. The leading market players are focusing on expanding their product portfolios.
Major market players in Interventional Oncology Industry are BTG plc , Medtronic, Boston Scientific, Terumo, Merit Medical, Sirtex, AngioDynamics, Ethicon, Teleflex , Cook Medical, HealthTronics, MedWaves Medical, Sanarus, IMBiotechnologies, Trod Medical, IceCure Medical, Mermaid Medicals, Interface Biomaterials BV, Guerbet, ABK Biomedical, Shape Memory Medical, Endo Shape, Monteris Medical, Instylla, and Trisalus Lifesciences.
Interventional Oncology Industry Segmentation:
Interventional Oncology Industry Overview, By Procedure
• Thermal Tumor Ablation
• Non-Thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization
• Transcatheter Arterial Embolization
Interventional Oncology Industry Overview, By Cancer Type
• Liver Cancer
• Lung Cancer
• Bone Cancer
• Kidney Cancer
• Other Cancers
Interventional Oncology Industry Overview, By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
呡
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10079041 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
